© The Rockefeller University Press, 0022-1007/1998/8/755/ $5.00
The Journal of Experimental Medicine, Volume 188, Number 4, August 17, 1998 755-763
Angiostatin-mediated Suppression of Cancer Metastases by Primary Neoplasms Engineered to Produce Granulocyte/Macrophage Colony–stimulating Factor
Zhongyun Dong,
Junya Yoneda,
Rakesh Kumar, and
Isaiah J. Fidler
From the Department of Cell Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030
We determined whether tumor cells consistently generating granulocyte/macrophage colony– stimulating factor (GM-CSF) can recruit and activate macrophages to generate angiostatin and, hence, inhibit the growth of distant metastasis. Two murine melanoma lines, B16-F10 (syngeneic to C57BL/6 mice) and K-1735 (syngeneic to C3H/HeN mice), were engineered to produce GM-CSF. High GM-CSF (>1 ng/106 cells)– and low GM-CSF (<10 pg/106 cells)–producing clones were identified. Parental, low, and high GM-CSF–producing cells were injected subcutaneously into syngeneic and into nude mice. Parental and low-producing cells produced rapidly growing tumors, whereas the high-producing cells produced slow-growing tumors. Macrophage density inversely correlated with tumorigenicity and directly correlated with steady state levels of macrophage metalloelastase (MME) mRNA. B16 and K-1735 subcutaneous (s.c.) tumors producing high levels of GM-CSF significantly suppressed lung metastasis of 3LL, UV-2237 fibrosarcoma, K-1735 M2, and B16-F10 cells, but parental or low-producing tumors did not. The level of angiostatin in the serum directly correlated with the production of GM-CSF by the s.c. tumors. Macrophages incubated with medium conditioned by GM-CSF– producing B16 or K-1735 cells had higher MME activity and generated fourfold more angiostatin than control counterparts. These data provide direct evidence that GM-CSF released from a primary tumor can upregulate angiostatin production and suppress growth of metastases.
Key Words: angiogenesis angiostatin granulocyte/macrophage colony–stimulating factor metastasis tumor
Address correspondence to Zhongyun Dong, Department of Cell Biology, Box 173, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030. Phone: 713-792-8523; Fax: 713-792-8747; E-mail: zdong{at}notes.mdacc.tmc.edu
Abbreviations used: BCE, bovine capillary endothelial cell(s); bFGF, basic fibroblast growth factor; FBS, fetal bovine serum; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; H, high (levels of GM-CSF– producing); LBS-1, plasminogen lysine–binding site 1; L, low (levels of GM-CSF–producing); MME, macrophage metalloelastase; PEM, peritoneal exudate macrophage(s).

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
-
Houghton, A. M., Grisolano, J. L., Baumann, M. L., Kobayashi, D. K., Hautamaki, R. D., Nehring, L. C., Cornelius, L. A., Shapiro, S. D.
(2006). Macrophage elastase (matrix metalloproteinase-12) suppresses growth of lung metastases.. Cancer Res.
66: 6149-6155
[Abstract]
[Full Text]
-
O'Mahony, D., Kummar, S., Gutierrez, M. E.
(2005). Non-Small-Cell Lung Cancer Vaccine Therapy: A Concise Review. JCO
23: 9022-9028
[Abstract]
[Full Text]
-
Matsunaga, T., Chilian, W. M., March, K.
(2005). Angiostatin is negatively associated with coronary collateral growth in patients with coronary artery disease. Am. J. Physiol. Heart Circ. Physiol.
288: H2042-H2046
[Abstract]
[Full Text]
-
Pan, H., Nguyen, N.-Q.-N., Yoshida, H., Bentzien, F., Shaw, L. C., Rentier-Delrue, F., Martial, J. A., Weiner, R., Struman, I., Grant, M. B.
(2004). Molecular Targeting of Antiangiogenic Factor 16K hPRL Inhibits Oxygen-Induced Retinopathy in Mice. IOVS
45: 2413-2419
[Abstract]
[Full Text]
-
Kaneko, Y., Sakatsume, M., Xie, Y., Kuroda, T., Igashima, M., Narita, I., Gejyo, F.
(2003). Macrophage Metalloelastase as a Major Factor for Glomerular Injury in Anti-Glomerular Basement Membrane Nephritis. J. Immunol.
170: 3377-3385
[Abstract]
[Full Text]
-
Pinedo, H.M., de Gruijl, T.D., van der Wall, E., Buter, J.
(2000). Biological Concepts of Prolonged Neoadjuvant Treatment plus GM-CSF in Locally Advanced Tumors. The Oncologist
5: 497-500
[Abstract]
[Full Text]
-
Gorrin-Rivas, M. J., Arii, S., Furutani, M., Mizumoto, M., Mori, A., Hanaki, K., Maeda, M., Furuyama, H., Kondo, Y., Imamura, M.
(2000). Mouse Macrophage Metalloelastase Gene Transfer into a Murine Melanoma Suppresses Primary Tumor Growth by Halting Angiogenesis. Clin. Cancer Res.
6: 1647-1654
[Abstract]
[Full Text]
-
Lawson, D., Kirkwood, J. M.
(2000). Granulocyte-Macrophage Colony-Stimulating Factor: Another Cytokine With Adjuvant Therapeutic Benefit in Melanoma?. JCO
18: 1603-1605
[Full Text]
-
Shinohara, H., Yano, S., Bucana, C. D., Fidler, I. J.
(2000). Induction of Chemokine Secretion and Enhancement of Contact-Dependent Macrophage Cytotoxicity by Engineered Expression of Granulocyte-Macrophage Colony-Stimulating Factor in Human Colon Cancer Cells. J. Immunol.
164: 2728-2737
[Abstract]
[Full Text]
-
Lu, W., J. Fidler, I., Dong, Z.
(1999). Eradication of Primary Murine Fibrosarcomas and Induction of Systemic Immunity by Adenovirus-mediated Interferon {{beta}} Gene Therapy. Cancer Res.
59: 5202-5208
[Abstract]
[Full Text]
-
Ito, D., Back, T. C., Shakhov, A. N., Wiltrout, R. H., Nedospasov, S. A.
(1999). Mice with a Targeted Mutation in Lymphotoxin-{alpha} Exhibit Enhanced Tumor Growth and Metastasis: Impaired NK Cell Development and Recruitment. J. Immunol.
163: 2809-2815
[Abstract]
[Full Text]